Benzinga | Dec 20, 2021 07:09AM EST

Berenberg Maintains Buy on Eli Lilly, Raises Price Target to $305

Berenberg analyst Kerry Holford maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $270 to $305.